August 2026 - Page 2 of 6 - NetworkNewsWire

TuesdayAug 25, 2026 1:50 pm

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Is ‘One to Watch’

FDA-approved LYMPHIR(TM) provides commercial-stage exposure to the oncology market. LYMPHIR(TM) generated $5.6 million in net revenue during the first six months of fiscal 2026 following its December 2025 commercial launch. Late-stage pipeline includes Mino-Lok(R), which met the primary and secondary endpoints of its pivotal Phase 3 trial. Diversified development portfolio targets critical-care indications with significant unmet medical needs. Halo-Lido could potentially become the first FDA-approved prescription product for the treatment of hemorrhoids in the United States. Stem cell platform provides an additional development opportunity targeting acute respiratory distress syndrome. Experienced leadership team has extensive pharmaceutical development, commercialization, sales, marketing and…

TuesdayAug 25, 2026 10:30 am

Silynxcom Ltd. (NYSE American: SYNX) Grows World Sales In a Rapidly Changing World, Fulfilling Increased Needs for Advanced Communication Headset System Technology

Silynx, producer of field-tested, certified, and combat-proven in-ear tactical communication headset systems, offers clear communication and situational awareness, along with hearing protection, to clients across multiple sectors including military, law enforcement, sport shooting, industrial, and riot control. The company’s tactical headsets are built on proprietary technologies that offer a blend of protection, communication, and comfort for operators who don’t compromise on effectiveness, comfort, and overall quality. Full tactical communication systems offer Silynx Drone Detection providing the ability to better hear and act upon distant drone activity Silynx world sales continue to expand, including a recent $3 million order of advanced…

TuesdayAug 25, 2026 9:45 am

India’s Medical-Device Market Surge Seen as Major Growth Opportunity for SS Innovations International Inc. (NASDAQ: SSII)

India’s medical-device market is projected to grow from $15.2 billion in 2025 to $50.1 billion by 2030, with the possible 26.9% CAGR creating a significant domestic and export opportunity for Indian medical-device manufacturers. SS Innovations is already commercializing the SSi Mantra surgical robotic system from its Indian base, having installed 224 SSi Mantra systems across 12 countries by June 30, providing an established platform as India expands its MedTech manufacturing ambitions. For SSII, India’s push to reduce medical-device import dependence could create opportunities extending beyond domestic sales into manufacturing, exports, and international technology adoption. The company is actively seeking both…

TuesdayAug 25, 2026 9:00 am

The Interception Gap: Directed Energy Solved Cost of Shooting Down Drones, Exposed a Harder Problem Underneath

NetworkNewsWire Editorial Coverage: For most of the past decade, counter-drone defense was framed as a capability question. It has quietly become a question of arithmetic, and the answer the defense establishment has converged on is directed energy, which trades a multimillion-dollar interceptor for a laser that fires for pennies. That fix has exposed a second and harder problem sitting underneath it. Aiming a laser demands a class of perception that most of the deployed world does not have, and the threat itself has just gone silent. Wrap Technologies Inc. (NASDAQ: WRAP) (Profile) has spent the summer assembling a position at…

TuesdayAug 25, 2026 9:00 am

Nano-X Imaging Ltd. (NASDAQ: NNOX) Is ‘One to Watch’

The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform spanning scan, analysis and interpretation. Nanox is expanding its commercial reach through its U.S. commercial activities and collaboration with healthcare organizations. First-quarter 2026 revenue increased to $4.3 million from $2.8 million in the prior-year period, with contributions from teleradiology, imaging systems, OEM services, AI, software and Health IT. Nanox has secured FDA clearance for Nanox.ARC, Nanox.ARC X and three Nanox.AI medical imaging solutions, while its commercial and clinical activities involve organizations including RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s…

MondayAug 24, 2026 11:15 am

MindWave Innovations Inc. (NYSE American: APUS) Is Helping Corporations Hold, Manage, and Generate Risk-Aware Yield on Bitcoin Reserves

MindWave Innovations is developing institutional-grade digital asset infrastructure designed to help corporations and institutions hold, manage and generate yield from Bitcoin reserves while combining traditional financial controls with blockchain efficiency. The company is expanding access to its ecosystem, with its native $NILA token now available to eligible U.S. users through Webot, providing a regulated pathway into the broader MindWaveDAO ecosystem. The expansion is expected to continue with the October 2026 launch of MindChain, an independent Layer 2 blockchain that MindWave describes as the world's first fully insured blockchain and a foundation for broader ecosystem development and real-world asset tokenization. As…

MondayAug 24, 2026 10:30 am

Frontieras North America Inc. Advances a Low-Sulfur Industrial Carbon That Heavy Industry Is Already Looking For

The challenge for steel and other heavy industries is not finding carbon; it is finding carbon that performs reliably without introducing sulfur into the process. FASCarbon(TM) is the solid carbon output of Frontieras's FASForm(TM) process, a continuous solid carbon fractionation system that thermally cracks coal without combustion. FASCarbon's low sulfur content makes it a direct substitute for higher-grade, more expensive carbon inputs in steelmaking and industrial heating applications. Coal has always been valued for what it produces when burned. Frontieras North America has built a business around what it produces when it isn't burned. The company's FASForm(TM) process fractionates coal into…

MondayAug 24, 2026 9:45 am

From Evaluation to Deployment: SPARC AI Inc.’s (CSE: SPAI) (OTCQB: SPAIF) Push into U.S. Public Safety with GPS-Independent Drone Technology

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI is expanding its push into the U.S. public safety market with GPS-independent target acquisition and navigation technology designed for drones and other autonomous systems. The company has established a dedicated U.S. Federal and Public Safety team focused on customer engagement, demonstrations, evaluations, systems integration and government procurement pathways. The new team is intended to help move Overwatch from field evaluations toward operational adoption across law enforcement, border security, search and rescue, disaster response and critical-infrastructure missions. SPARC AI (CSE: SPAI) (OTCQB: SPAIF)…

MondayAug 24, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

Following completion of the initial phase of its collaboration with OmniAb, VERAXA will engineer the final VXA-222 candidate and conduct the preclinical validation needed to determine the program’s next development steps. VXA-222 uses an “AND-gate” approach designed to recognize two tumor-associated antigens simultaneously before delivering its therapeutic payload. The company has separately filed its first patents related to its BiTAC-TCE and BiTAC-ADC platforms while expanding protection around antibody conjugation and payload technologies. The company is building a diversified oncology pipeline spanning bispecific T-cell engagers, ADCs, and other engineered antibody formats. VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel…

FridayAug 21, 2026 11:15 am

Frontieras North America Inc. Positions Domestic Coal as America’s Answer to Energy Supply Disruption

The United States sits on a significant coal resource base. FASForm produces six commercial outputs from a single coal input: diesel, naphtha, jet fuel, ammonium sulfate fertilizer, sulfuric acid and FASCarbon(TM). Frontieras is moving this technology from development into construction. The Strait of Hormuz closure that began in late February 2026 removed more than 11 million barrels of Middle Eastern crude per day from global markets and sent Brent crude from roughly $62 a barrel in December 2025 to more than $117 by April 2026. Diesel and jet fuel wholesale prices are forecast to rise more than 60% in 2026…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: August 2026